Hyperbaric Oxygen Therapy

HBOT, in combination with SGB, treats several conditions, including PTSD, Trauma, and addiction.

• • Enhanced Bone Healing and Bone Density: HBOT promotes bone healing processes by increasing oxygen delivery to bones. This can be beneficial in cases of osteoporosis-related fractures, helping to support bone repair and potentially improving bone density over time.
• Improved Muscle Mass and Function: For patients with Cachexia (general weakness, weight loss, muscle loss), which often involves muscle atrophy and loss of muscle mass, HBOT may help by supporting muscle tissue repair and regeneration. Increased oxygenation can enhance cellular metabolism and protein synthesis, which are essential for maintaining muscle health.
• Anti-inflammatory Effects: Chronic inflammation is common in both osteoporosis and Cachexia. HBOT has anti-inflammatory properties that can help reduce inflammation in bones and tissues, potentially slowing bone loss and mitigating muscle loss.
• Support for Tissue Repair and Regeneration: HBOT promotes angiogenesis (formation of new blood vessels) and stimulates tissue repair mechanisms. This can be beneficial for both bones and muscles affected by osteoporosis and Cachexia, supporting overall tissue health and function.
• Pain Relief: Both osteoporosis and Cachexia can cause significant pain and discomfort. HBOT has been reported to provide pain relief in various conditions, which could help improve quality of life for patients dealing with chronic pain from these conditions.
• Improved Overall Health and Quality of Life: By enhancing oxygen delivery and supporting tissue repair, HBOT may contribute to improved overall health, physical function, and quality of llife for patients managing both osteoporosis and Cachexia.!

HBOT – Mechanisms to Address Interstitial Lung Disease (ILD)

Traditional treatments for interstitial lung disease (ILD) typically include:

1. Medications:

2. Oxygen therapy:

3. Pulmonary rehabilitation:

4. Lifestyle changes:

5. Surgery:

6. Supportive care:

Specific treatment approaches for ILD depend upon the underlying cause and severity of the ILD. Treatment goals are typically to slow disease progression, improve quality of life, and in some cases, reverse the effects of ILD. Many patients receive a combination of these treatments as part of a comprehensive management plan.

As a complement to traditional ILD treatments, Regenesis offers hyperbaric oxygen therapy (HBOT) due to HBOT’s important anti-inflammatory, anti-bacterial, anti-viral and immunomodulation properties. These and other properties of HBOT work in support of traditional treatments to suppress inflammation and immune response, support tissue oxygenation, slow fibrosis, and fend off opportunistic respiratory infections that may arise with ILD. HBOT has the potential to slow disease progression and support ILD patient quality of life through several potential mechanisms of action:

1. Reduced inflammation: HBOT has been shown to have anti-inflammatory effects with the potential to help reduce lung inflammation associated with ILD.
2. Improved oxygenation: By delivering high concentrations of oxygen under pressure, HBOT can significantly increase oxygen levels in the blood and tissues, potentially improving oxygenation in damaged lung tissue.
3. Fibroblast inhibition: HBOT may help inhibit fibroblast activation and extracellular matrix production, which are key processes in the development of pulmonary fibrosis.
4. Downregulation of TGF-ß and HIF-1a: HBOT has been found to downregulate the expression of transforming growth factor-beta (TGF-ß) and hypoxia-inducible factor-1 alpha (HIF-1a), both of which play important roles in fibrosis development.
5. Enhanced tissue repair: The increased oxygen levels provided by HBOT can promote tissue repair and regeneration, potentially helping to heal damaged lung tissue. HBOT also can mobilize stem cells and cause stem cells to implant in damaged tissue. Through this mechanism, HBOT can foster lung tissue repair and regeneration. Mesenchymal Stem Cells (MSCs), that comprise a share of total autologous stem cells mobilized by HBOT have immunomodulatory properties that can reduce inflammation in the lungs. They also have the potential to secrete anti- inflammatory mediators and modulate a patient’s immune response to create a favorable environment for tissue healing.
6. Improved exercise capacity: Studies have shown that oxygen therapy in general can increase exercise capacity in patients with ILD affording potential quality of life improvements.

Cellular and HBOT – Mechanisms to Address Arachnoiditis

Hyperbaric oxygen therapy (HBOT) combined with mesenchymal stem cell (MSC) and exosome infusion (cellular therapy) can potentially benefit patients with arachnoiditis through several synergistic mechanisms:

Anti-Inflammatory Effects. HBOT can reduce inflammation by decreasing the activation of pro-inflammatory M1 macrophages and reducing the production of inflammatory cytokines like TNF-a. MSCs and their exosomes have the potential to modulate the immune response, shifting macrophages towards an anti-inflammatory M2 phenotype and secreting anti-inflammatory factors. This combined anti-inflammatory action may significantly reduce the chronic inflammation associated with arachnoiditis.

Improved Tissue Repair and Regeneration. The combination HBOT and biologic infusion therapy may enhance tissue repair processes. HBOT stimulates angiogenesis and improves blood flow to affected areas. MSCs and exosomes promote tissue regeneration by secreting growth factors and supporting cell survival. The increased oxygen levels from HBOT may enhance the survival and efficacy of transplanted MSCs.

Neuroprotection and Neuroplasticity. Both HBOT and stem cell therapy offer neuroprotective benefits. HBOT can reduce oxidative stress by increasing antioxidant enzyme activity and decreasing free radical production. MSCs and exosomes can provide neuroprotection through the release of neurotrophic factors. In combination HBOT and biologics may enhance neuroplasticity and promote the formation of new neural connections.

Myelin Repair. Arachnoiditis can lead to demyelination of nerve roots. The combined HBOT and biologic infusion therapy may support remyelination. HBOT has been shown to upregulate myelin basic protein (Mbp) expression and increase remyelination processes in animal models. MSCs and their exosomes have demonstrated the ability to promote oligodendrocyte differentiation and myelin repair.

Mitochondrial Function and Cellular Energy. The therapy combination could improve cellular energy production. HBOT enhances mitochondrial function and restores mitochondrial integrity. MSCs and exosomes can transfer healthy mitochondria to damaged cells, improving their energy metabolism.

Reduction of Fibrosis and Scarring. Arachnoiditis often involves the formation of scar tissue. The combined therapy may help reduce fibrosis. HBOT has been shown to reduce glial scar formation in spinal cord injuries. MSCs and exosomes have anti-fibrotic properties and may help remodel existing scar tissue.